Rising Cardiovascular Disease Prevalence and Advancements in Diagnostic Technologies Propel Market GrowthPune, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Cardiac Biomarker Testing Market Size & Growth Analysis ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...

Acute coronary syndrome (ACS) is a term used to describe a range of conditions resulting from the sudden reduction or ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new ...

The following is a summary of “Prognostic role of cardiac and inflammatory biomarkers in extubation failure in patients with COVID-19 acute respiratory distress syndrome,” published in the January ...

Introduction: Atrial fibrillation (AF) is the most prevalent form of cardiac arrhythmia worldwide. Early diagnosis and treatment are essential, emphasizing the need to develop novel biomarkers.